Natalizumab LC46-58 KSN deimmunised
LLIHYTKSNQPGI-acid
Description
Application Data
Description
-
Natalizumab LC46-58 KSN deimmunised
Application Data
-
Catalogue number crb1001728 Molecular Weight 1482.8 Sequence (one letter code) LLIHYTKSNQPGI-acid
Sequence (three letter code) H-Leu-Leu-Ile-His-Tyr-Thr-Lys-Ser-Asn-Gln-Pro-Gly-Ile-OH
Purity >95% Manufactured in: United Kingdom Natalizumab LC46-58 KSN deimmunised